Skip to main content
Erschienen in: Osteoporosis International 8/2014

01.08.2014 | Original Article

Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus

verfasst von: R. Jiajue, Y. Jiang, O. Wang, M. Li, X. Xing, L. Cui, J. Yin, L. Xu, W. Xia

Erschienen in: Osteoporosis International | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Summary

We found that type 2 diabetes mellitus (T2DM) was associated with increased fracture risks in non-obese postmenopausal Chinese women, and suppressed bone turnover might be the underlying mechanism. This is the first study evaluating and explaining the association of T2DM with osteoporotic fracture in Chinese population with such high homogeneity.

Introduction

The aim of this study was to investigate the association of T2DM with osteoporotic fracture in postmenopausal Chinese women.

Methods

One thousand four hundred ten postmenopausal women were included and stratified into non-obese population [body mass index (BMI) < 25 kg/m2] and obese population (BMI ≥ 25 kg/m2). Each type of population was classified into diabetes group, impaired fasting glucose (IFG) group, and normal glucose group. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry. Serum C-terminal telopeptide of type I collagen (β-CTX) and serum N-amino terminal prepeptide of type 1 procollagen (P1NP) were quantified. Vertebral fractures (VFs) and non-VFs were assessed by vertebral X-ray and questionnaire, respectively.

Results

Comparing to normal glucose group, diabetes group and IFG group both had lower levels of P1NP and β-CTX, despite population types. Despite having non-decreased BMD, non-obese diabetic patients had higher risks of total fracture and VF than BMI-matched normal glucose subjects (both P < 0.05). Non-obese population was further classified by a mean value of P1NP or β-CTX. Non-obese diabetic patients with low P1NP or high β-CTX had higher fracture risks (both P < 0.05), comparing to non-obese normal glucose subjects with high P1NP or high β-CTX, respectively.

Conclusions

Type 2 diabetic patients had suppressed bone turnover, which might explain the increased fracture risks, independent of BMD. IFG patients might also have poor bone quality and need early prevention.
Literatur
1.
Zurück zum Zitat Heath H, Melton LJ, Chu CP (1980) Diabetes mellitus and risk of skeletal fracture. N Engl J Med 303:567–570PubMedCrossRef Heath H, Melton LJ, Chu CP (1980) Diabetes mellitus and risk of skeletal fracture. N Engl J Med 303:567–570PubMedCrossRef
2.
Zurück zum Zitat Forsen L, Meyer HE, Midthjell K, Edna TH (1999) Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 42:920–925PubMed Forsen L, Meyer HE, Midthjell K, Edna TH (1999) Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 42:920–925PubMed
3.
Zurück zum Zitat Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral anti-diabetic medication on relative fracture risk. Diabetologia 48:1292–1299PubMedCrossRef Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral anti-diabetic medication on relative fracture risk. Diabetologia 48:1292–1299PubMedCrossRef
4.
Zurück zum Zitat Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T (2009) Diabetic patients have an increased risk of vertebral fractures independent of bone mineral density or diabetic complications. J Bone Miner Res 24:702–709PubMedCrossRef Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T (2009) Diabetic patients have an increased risk of vertebral fractures independent of bone mineral density or diabetic complications. J Bone Miner Res 24:702–709PubMedCrossRef
5.
Zurück zum Zitat Tuominen JT, Impivaara O, Puukka P, Ronnemaa T (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22:1196–1200PubMedCrossRef Tuominen JT, Impivaara O, Puukka P, Ronnemaa T (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22:1196–1200PubMedCrossRef
6.
Zurück zum Zitat Sosa M, Dominquez M, Navarro MC, Segarra MC, Hernandez D, de Pablos P, Betancor P (1996) Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J Diabetes Complicat 10:201–205PubMedCrossRef Sosa M, Dominquez M, Navarro MC, Segarra MC, Hernandez D, de Pablos P, Betancor P (1996) Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J Diabetes Complicat 10:201–205PubMedCrossRef
7.
Zurück zum Zitat van Daele PL, Stolk RP, Burger H, Algra D, Grobbee DE, Hofman A, Birkenhager JC, Pols HA (1995) Bone density in non-insulin-dependent diabetes mellitus: the Rotterdam Study. Ann Intern Med 122:409–414PubMedCrossRef van Daele PL, Stolk RP, Burger H, Algra D, Grobbee DE, Hofman A, Birkenhager JC, Pols HA (1995) Bone density in non-insulin-dependent diabetes mellitus: the Rotterdam Study. Ann Intern Med 122:409–414PubMedCrossRef
8.
Zurück zum Zitat Sahin G, Bagis S, Cimen OB, Ozisik S, Guler H, Erdogan C (2001) Lumbar and femoral bone mineral density in type 2 Turkish diabetic patients. Acta Med (Hradec Kralove) 44:141–143 Sahin G, Bagis S, Cimen OB, Ozisik S, Guler H, Erdogan C (2001) Lumbar and femoral bone mineral density in type 2 Turkish diabetic patients. Acta Med (Hradec Kralove) 44:141–143
9.
Zurück zum Zitat Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T (2012) Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 97:1277–1284PubMedCrossRef Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T (2012) Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 97:1277–1284PubMedCrossRef
10.
Zurück zum Zitat Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359PubMedCrossRef Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359PubMedCrossRef
11.
Zurück zum Zitat Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF et al (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365:1398–1405PubMedCrossRef Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF et al (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365:1398–1405PubMedCrossRef
12.
Zurück zum Zitat Torrens JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M et al (2004) Study of women’s health across the nation (SWAN). Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early premenopausal women without diabetes: the study of women’s health across the nation (SWAN). Diabetes Care 27:354–361PubMedCrossRef Torrens JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M et al (2004) Study of women’s health across the nation (SWAN). Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early premenopausal women without diabetes: the study of women’s health across the nation (SWAN). Diabetes Care 27:354–361PubMedCrossRef
13.
Zurück zum Zitat Zhou Y, Li Y, Zhang D, Wang J, Yang H (2010) Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Res Clin Pract 90:261–269PubMedCrossRef Zhou Y, Li Y, Zhang D, Wang J, Yang H (2010) Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Res Clin Pract 90:261–269PubMedCrossRef
14.
Zurück zum Zitat Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W (2011) The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study. Menopause 18:1237–1243PubMedCrossRef Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W (2011) The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study. Menopause 18:1237–1243PubMedCrossRef
15.
Zurück zum Zitat Yudkin J (1983) Obesity: a report of the Royal College of Physicians. J R Coll Phys Lond 17:5–65 Yudkin J (1983) Obesity: a report of the Royal College of Physicians. J R Coll Phys Lond 17:5–65
16.
Zurück zum Zitat Zhang ZH, Shen JX, Liu ZH (2005) Retrospective study on standardization of BMD machines in China. Chin J Osteoporos 11:133–145 Zhang ZH, Shen JX, Liu ZH (2005) Retrospective study on standardization of BMD machines in China. Chin J Osteoporos 11:133–145
17.
Zurück zum Zitat Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef
18.
Zurück zum Zitat Shu A, Yin MT, Stein E, Cremers S, Dworakowski E, Ives R, Rubin MR (2012) Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int 23:635–641PubMedCentralPubMedCrossRef Shu A, Yin MT, Stein E, Cremers S, Dworakowski E, Ives R, Rubin MR (2012) Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int 23:635–641PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Rasul S, Ilhan A, Wagner L, Luger A, Kautzky-Willer A (2012) Diabetic polyneuropathy relates to bone metabolism and markers of bone turnover in elderly patients with type 2 diabetes: greater effects in male patients. Gend Med 9:187–196PubMedCrossRef Rasul S, Ilhan A, Wagner L, Luger A, Kautzky-Willer A (2012) Diabetic polyneuropathy relates to bone metabolism and markers of bone turnover in elderly patients with type 2 diabetes: greater effects in male patients. Gend Med 9:187–196PubMedCrossRef
20.
Zurück zum Zitat Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613–620PubMedCrossRef Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613–620PubMedCrossRef
21.
Zurück zum Zitat Botolin S, McCabe LR (2007) Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 148:198–205PubMedCrossRef Botolin S, McCabe LR (2007) Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 148:198–205PubMedCrossRef
22.
Zurück zum Zitat Ferrer-Lorente R, Bejar MT, Tous M, Vilahur G, Badimon L (2013) Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function. Diabetologia 57:246–256PubMedCrossRef Ferrer-Lorente R, Bejar MT, Tous M, Vilahur G, Badimon L (2013) Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function. Diabetologia 57:246–256PubMedCrossRef
23.
Zurück zum Zitat Botolin S, McCabe LR (2006) Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99:411–424PubMedCrossRef Botolin S, McCabe LR (2006) Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99:411–424PubMedCrossRef
24.
Zurück zum Zitat Catalfamo D, Britten T, Storch D, Calderon N, Sorenson H, Wallet S (2013) Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast function. Oral Dis 19:303–312PubMedCentralPubMed Catalfamo D, Britten T, Storch D, Calderon N, Sorenson H, Wallet S (2013) Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast function. Oral Dis 19:303–312PubMedCentralPubMed
25.
Zurück zum Zitat McCabe LR (2007) Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102:1343–1357PubMedCrossRef McCabe LR (2007) Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102:1343–1357PubMedCrossRef
26.
Zurück zum Zitat de Paula FJ, Horowitz MC, Rosen CJ (2010) Novel insights into the relationship between diabetes and osteoporosis. Diabetes Metab Res Rev 26:622–630PubMedCentralPubMedCrossRef de Paula FJ, Horowitz MC, Rosen CJ (2010) Novel insights into the relationship between diabetes and osteoporosis. Diabetes Metab Res Rev 26:622–630PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Barrera G, Bunout D, Gattas V, de la Maza MP, Leiva L, Hirsch S (2004) A high body-mass index protects against femoral neck osteoporosis in health elderly subjects. Nutrition 20:769–771PubMedCrossRef Barrera G, Bunout D, Gattas V, de la Maza MP, Leiva L, Hirsch S (2004) A high body-mass index protects against femoral neck osteoporosis in health elderly subjects. Nutrition 20:769–771PubMedCrossRef
28.
Zurück zum Zitat Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8:567–573PubMedCrossRef Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8:567–573PubMedCrossRef
29.
Zurück zum Zitat Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates AJ, Christiansen C (1999) Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res 14:1622–1627PubMedCrossRef Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates AJ, Christiansen C (1999) Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res 14:1622–1627PubMedCrossRef
30.
Zurück zum Zitat Petit MA, Paudel ML, Taylor BC, Hughes JM, Strotmeyer ES, Schwartz AV et al (2010) Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res 25:285–291PubMedCentralPubMedCrossRef Petit MA, Paudel ML, Taylor BC, Hughes JM, Strotmeyer ES, Schwartz AV et al (2010) Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res 25:285–291PubMedCentralPubMedCrossRef
Metadaten
Titel
Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus
verfasst von
R. Jiajue
Y. Jiang
O. Wang
M. Li
X. Xing
L. Cui
J. Yin
L. Xu
W. Xia
Publikationsdatum
01.08.2014
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 8/2014
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-014-2714-5

Weitere Artikel der Ausgabe 8/2014

Osteoporosis International 8/2014 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.